![Jean-Pierre Lehner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jean-Pierre Lehner
Directeur Général chez
YSOPIA Biosciences SA
Profil
Jean-Pierre Lehner currently works at YSOPIA Biosciences SA, as Chairman & General Manager from 2022, AptamiR Therapeutics, Inc., as Director, Eligo Bioscience SA, as Director, and Curio Digital Therapeutics, Inc., as Director.
Dr. Lehner also formerly worked at Sanofi, as Chief Medical Officer & Senior Vice President from 2009 to 2013 and Sanofi-Aventis U.S.
LLC, as Chief Medical Officer & Senior Vice President.
Dr. Lehner received his doctorate degree from Université Paris 1 Panthéon-Sorbonne.
Postes actifs de Jean-Pierre Lehner
| Sociétés | Poste | Début |
|---|---|---|
Eligo Bioscience SA
 Eligo Bioscience SA Miscellaneous Commercial ServicesCommercial Services Operates as a proprietary platform to edit the microbiome gene repertoire | Directeur/Membre du Conseil | - |
YSOPIA Biosciences SA
 YSOPIA Biosciences SA BiotechnologyHealth Technology Develops therapeutic solutions for metabolic and cardiometabolic disorders | Directeur Général | 08/04/2022 |
AptamiR Therapeutics, Inc.
 AptamiR Therapeutics, Inc. BiotechnologyHealth Technology Operates as a bio technology company that develops therapeutics for obesity and ovarian cancer | Directeur/Membre du Conseil | - |
Curio Digital Therapeutics
 Curio Digital Therapeutics Packaged SoftwareTechnology Services Provides digital behavioral health services for women | Directeur/Membre du Conseil | - |
Anciens postes connus de Jean-Pierre Lehner
| Sociétés | Poste | Fin |
|---|---|---|
| SANOFI | Directeur Technique/Scientifique/R&D | 01/01/2013 |
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Develops medicines, vaccines and provides specialized healthcare & clinical trail services | Directeur Technique/Scientifique/R&D | 31/12/2012 |
Formation de Jean-Pierre Lehner
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
55
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Université Paris 1 Panthéon-Sorbonne
 Université Paris 1 Panthéon-Sorbonne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Develops medicines, vaccines and provides specialized healthcare & clinical trail services | Health Technology |
YSOPIA Biosciences SA
YSOPIA Biosciences SA BiotechnologyHealth Technology Develops therapeutic solutions for metabolic and cardiometabolic disorders | Health Technology |
AptamiR Therapeutics, Inc.
AptamiR Therapeutics, Inc. BiotechnologyHealth Technology Operates as a bio technology company that develops therapeutics for obesity and ovarian cancer | Health Technology |
Eligo Bioscience SA
Eligo Bioscience SA Miscellaneous Commercial ServicesCommercial Services Operates as a proprietary platform to edit the microbiome gene repertoire | Commercial Services |
Curio Digital Therapeutics
Curio Digital Therapeutics Packaged SoftwareTechnology Services Provides digital behavioral health services for women | Technology Services |
